Some prominent chess players said the sponsorship could help elevate women in chess, where they have long been underrepresented. As of last year, among the more than 1,700 regular grandmasters worldwide, only 37 were women.
Jovanka Houska, a nine-time British champion, told Chess.com that it “could be a very exciting sponsorship deal but it’s highly dependent on how FIDE promotes and frames it.”
“As pointed out by many, breast reconstruction surgery is a very worthwhile cause,” Ms. Houska told the website. “I also want to stress that women should not be scorned/ridiculed for electing to have breast enlargement surgery. I say this because there does seem to be a rather judgmental undertone on social media.”
Chess.com, which was covering the tournament in Spain and preparing to cover other women’s competitions, said on Saturday that it would “not be promoting Motiva as a sponsor in our broadcasts of these events.”
“We do recognize the importance of reconstructive surgery and supporting breast cancer survivors, and we also respect that elective plastic surgery is a personal and positive choice for some,” Chess.com wrote. “However, as a company, Chess.com does not feel this sponsorship association is positive for women’s chess or an appropriate marketing promotion to the broader Chess.com community.”
Beatriz Marinello, a past president of the U.S. Chess Federation and a past vice president of FIDE, and the first woman elected to both positions, said it had been “extremely difficult” to find sponsors for women’s events.
“We haven’t been prioritized,” she said in an interview on Saturday.
While Ms. Marinello said she wasn’t personally offended by the partnership with Establishment Labs, “my only concern is targeting teenagers or girls who don’t have any medical condition and may decide to do this to make them look better.”